Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.

Bibliografski detalji
Glavni autori:	Porto, I, Banning, A
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
od: Alain Guidon, i dr.
Izdano: (2008-01-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
od: Hang Ouyang, i dr.
Izdano: (2021-04-01)

Paclitaxel eluting stents versus bare metal stents restenosis
od: Ronald Aroche Aportela, i dr.
Izdano: (2021-12-01)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
od: Nisha Ohri, MD, i dr.
Izdano: (2016-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
od: Michał Hawranek, i dr.
Izdano: (2021-12-01)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
od: Raghav Sharma, i dr.
Izdano: (2022-02-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
od: А. Н. Кудряшов, i dr.
Izdano: (2017-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
od: Negar Faramarzi, i dr.
Izdano: (2015-10-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
od: Blackman, D, i dr.
Izdano: (2003)

Sirolimus-eluting coronary stents: a review
od: Alexandre Abizaid
Izdano: (2007-05-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
od: Violeta Dinesch, i dr.
Izdano: (2017-04-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
od: Sohila Refahi, i dr.
Izdano: (2019-03-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
od: Guillaume Marquis-Gravel, i dr.
Izdano: (2017-09-01)

Outcomes of supraflex sirolimus eluting coronary stents
od: Vishal Virendra Singh, i dr.
Izdano: (2022-01-01)

Outcomes of supraflex Sirolimus-eluting coronary stents
od: Vishal Virendra Singh, i dr.
Izdano: (2022-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
od: Iraj Jafaripour, i dr.
Izdano: (2023-05-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
od: Matthijs A Velders, i dr.
Izdano: (2014-01-01)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
od: Abizaid, A, i dr.
Izdano: (2012)

Study to assess clinical outcomes of an everolimus-eluting stent (EES) versus a sirolimus-eluting stent (SES)
od: Amit Madaan, i dr.
Izdano: (2015-12-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
od: Luo Y, i dr.
Izdano: (2022-02-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents.
od: Matthijs A. Velders, i dr.
Izdano: (2013-01-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
Izdano: (2013-01-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
od: Ryota Kakizaki, i dr.
Izdano: (2020-10-01)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
od: Alaide Chieffo, i dr.
Izdano: (2007-09-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
od: Blackman, D, i dr.
Izdano: (2004)

Trombose coronariana tardia secundária a implante de stent com paclitaxel sem reestenose dos stents convencionais Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents
od: Luciano Maurício de Abreu, i dr.
Izdano: (2007-05-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
od: Mohammad Saifur Rohman, i dr.
Izdano: (2023-07-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
od: Yang O, i dr.
Izdano: (2024-11-01)

Risk assessment score for drug eluting stent restenosis
od: Z. A. Gabbasov, i dr.
Izdano: (2018-09-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
od: Kazunori Horie, MD, i dr.
Izdano: (2025-01-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
od: Hasan Shemirani, i dr.
Izdano: (2011-09-01)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
od: Satoshi Suzuki, i dr.
Izdano: (2020-01-01)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
od: Juan F. Iglesias, i dr.
Izdano: (2019-11-01)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
od: Igor Kranjec, i dr.
Izdano: (2009-01-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
od: I Gusti Ayu Ratna Dewi, i dr.
Izdano: (2023-06-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
od: Ali S. Almasood, i dr.
Izdano: (2011-01-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
od: Dauer Cheryl, i dr.
Izdano: (2005-12-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
od: Kakhaber Etsadashvili, i dr.
Izdano: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
od: Yen-Wen Liu, i dr.
Izdano: (2021-09-01)

Early-Period Coronary Aneurysm Formation After Sirolimus-Eluting Stent Implantation
od: Cihad Kaya, i dr.
Izdano: (2023-10-01)